Follow Us On

Facebook  X  Linkedin  YouTube
 
 
 

A 35-year bibliometric analysis of global trends in randomized controlled trials for chronic pain therapy (1989-2024) highlights Laxmaiah Manchikanti, MD, as a prominent author with the highest publication counts, while Pain Physician ranks as the third highest ranked journal.


The study, conducted by Yang et al., analyzed 4,206 publications from 939 journals, authored by 20,068 individuals across 86 countries. The most cited article was “Clinical Importance of Changes in Chronic Pain Intensity Measured on an 11-Point Numeric Pain Rating Scale” (Pain. 2001 Nov;94(2):149-158).


Most Published and Cited Authors:

  1. Laxmaiah Manchikanti, MD
  2. Andrew R. Moore, DSc
  3. Derry Sheena, MA


Top cited high-impact journals include:

  • Pain
  • Cochrane Database of Systematic Reviews
  • Pain Physician


The tables below summarize:

  • Publication and citation profiles of high-impact authors
  • Bibliometric indicators of high-impact journals

When certain legislative payment provisions (“extenders”) are scheduled to expire, CMS directs all Medicare Administrative Contractors (MACs) to implement a temporary claims hold. This standard practice is typically up to 10 business days and ensures that Medicare payments are accurate and consistent with statutory requirements. The hold prevents the need for reprocessing large volumes of claims should Congress act after the statutory expiration date. This should have a minimal impact on providers due to the 14-day payment floor. Providers may continue to submit claims during this period, but payment will not be released until the hold is lifted.


Absent Congressional action, beginning October 1, 2025, many of the statutory limitations that were in place for Medicare telehealth services before the COVID-19 Public Health Emergency will take effect again for services that are not behavioral and mental health services. These include prohibition of many services provided to beneficiaries in their homes, outside of rural areas, and hospice recertifications that require a face-to-face encounter. In some cases, these restrictions can impact requirements for meeting continued eligibility for other Medicare benefits. In the absence of Congressional action, practitioners who choose to perform telehealth services that are not payable by Medicare on or after October 1, 2025, may want to evaluate providing beneficiaries with an Advance Beneficiary Notice of Noncoverage. Practitioners should monitor Congressional action and may choose to hold claims associated with telehealth services that are not payable by Medicare in the absence of Congressional action. Additionally, Medicare would not be able to pay some kinds of practitioners for telehealth services.

Click here for more information 


CMS notes that the Bipartisan Budget Act of 2018 allows clinicians in applicable Medicare Shared Savings Program Accountable Care Organizations (ACOs) to provide and receive payment for covered telehealth services to certain Medicare beneficiaries without geographic restriction and in the beneficiary’s home. There is no special application or approval process for applicable ACOs or their ACO participants or ACO providers/suppliers. Clinicians in applicable ACOs can provide these covered telehealth services and bill Medicare for the telehealth services that are permissible under Medicare rules during CY 2025, irrespective of further Congressional action.

Click here for more information  


MACs will continue to perform all functions related to Medicare Fee-for-Service claims processing and payment.

Stay up-to-date with news that impacts you - visit our website or follow us on these social media platforms:

Facebook  LinkedIn  X  YouTube

ASIPP continues working for YOU!

Our unwavering dedication to tackling the critical issues that matter most to our members creates a vibrant tapestry of community and collaboration among healthcare heroes. As we navigate the ever-changing currents of the healthcare landscape, we’re not just keeping our fingers on the pulse; we’re amplifying your voices to ensure that your needs are front and center! Together, we’re crafting a future where your concerns shape effective policies and practices. 


Here are a few recently published Pain Physician articles:

Health Policy Perspective - Pain Physician


Physician Payment Reform in Interventional Pain Management: Balancing Cost, Quality, Access, and Survival of Independent Practices


Laxmaiah Manchikanti, MD, Mahendra Sanapati, MD, Vidyasagar Pampati, MSc, Paul J. Hubbell, III, MD, Ann Conn, MD, Ramarao Pasupuleti, MD, Mayank Gupta, MD, Alan D. Kaye, MD, PhD, Alaa Abd-Elsayed, MD, Annu Navani, MD, Miles Day, MD, Devi Nampiaparampil, MD, Christopher G. Gharibo, MD, and Joshua A. Hirsch, MD


Abstract | PDF

 

Health Policy Perspective - Pain Physician


Escalating Growth of Spending on Medicare Advantage Plans: Save Medicare from Insolvency and Balance the Budget


Laxmaiah Manchikanti, MD, Mahendra Sanapati, MD, Paul J. Hubbell, III, MD, Ann Conn, MD, Mayank Gupta, MD, Ramarao Pasupuleti, MD, Alaa Abd-Elsayed, MD, and Alan D. Kaye, MD, PhD


Abstract | PDF

 

Health Policy Perspective - Pain Physician


Non-Partisan Proposal for Reforming Physician Payment System and Preserving Telehealth Services


Laxmaiah Manchikanti, MD, Paul J. Hubbell, III, MD, Ramarao Pasupuleti, MD, Ann Conn, MD, and Mahendra Sanapati, MD


Abstract | PDF

 

Health Policy Review - Pain Physician


BMJ Publications on Interventional Techniques Do Not Meet Appropriateness Criteria of Conducting a Rapid Review: A Comprehensive Review


Laxmaiah Manchikanti, MD, Mahendra Sanapati, MD, Amol Soin, MD, Alan D. Kaye, MD, PhD, Alaa Abd-Elsayed, MD, Christopher G. Gharibo, MD, Allen Dennis, MD, and Joshua A. Hirsch, MD


Abstract | PDF

 

CMS issued the proposed rule CMS-1832-P on July 16, 2025, titled Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program.

 

On September 11, 2025, ASIPP submitted a comment letter advocating for the following:

 

  1. Elimination of proposed efficiency adjustment, which is inappropriate, and efficiency is rather decreasing than increasing.
  2. Due to escalating costs, practice expense cuts applicable to independent physicians need to be addressed.
  3. Ambulatory Specialty Model (ASM) appears to be without any evidence and inappropriate, putting independent physicians at high risk for survival; consequently, this should be eliminated or conducted on a voluntary trial for five years.
  4. Telehealth services must be made permanent.

 

Here are ASIPP’s detailed comment letter, Chairman Comer’s recent letter to CMS and OMB, and 3 published articles addressing this issue:

 

Stay up-to-date with news that impacts you - visit our website or follow us on these social media platforms:

Facebook  LinkedIn  X  YouTube

Register now for these ASIPP webinars!

Don’t miss the opportunity to engage with leading experts on October 21, 2025 as we explore how AI is transforming electronic health records and prescribing practices. This webinar is the first in a six-part series: the Modernizing Your Practice Through Medical Technology.

Each session focuses on a timely topic shaping the future of patient care—from electronic health records and AI prescribing to emerging tools that enhance efficiency, accuracy, and outcomes. Stay engaged each month and gain insights you can put into practice right away.

Join ASIPP on January 17, 2026, for an important webinar: Unveiling the Complexities of Controlled Substance Management in Interventional Pain Management (IPM).


Controlled substance management continues to present challenges for pain physicians, from evolving regulations and compliance requirements to balancing patient care with risk mitigation. This webinar will provide expert guidance to help you navigate these complexities and strengthen your practice.

Join ASIPP on January 31, 2026, for our webinar Strategies for Successful Practice Management. This program will focus on practical approaches to strengthen your practice through improved documentation, compliance strategies, and effective practice-building techniques.


Whether you are looking to optimize workflows, ensure regulatory readiness, or position your practice for long-term growth, this webinar will provide valuable insights to support your success.

Risks of Tramadol Likely Outweigh
Benefit for Chronic Pain

Drug didn't meet efficacy threshold and doubled serious
adverse event risk, analysis suggests

 

Key Takeaways


• Tramadol reduced chronic pain but the effect was below a predefined threshold, data from 19 trials suggested.



• Serious adverse events were higher with tramadol versus placebo.



• Most trials had a high risk of bias, possibly overstating tramadol's benefits and understating its harms.

The opioid analgesic tramadol reduced chronic pain levels compared with placebo, but appeared to double the risk of harm, a review of 19 clinical trials suggested.


In a meta-analysis and trial sequential analysis, tramadol improved chronic pain on the numerical rating scale (NRS) with low certainty of evidence (mean NRS difference -0.93 points, 97.5% CI -1.26 to -0.60, P<0.0001), said Jehad Ahmad Barakji, MD, of the Centre for Clinical Intervention Research at Rigshospitalet in Copenhagen, Denmark, and co-authors.


Click here to read the full article.

Join Us in New Orleans for ASIPP 2026

Earn CMEs, Expand Networks, and Explore the Future of Pain Management

It is our pleasure to invite you to the American Society of Interventional Pain Physicians’ 2026 Annual Meeting, where we will continue to shape the future of Interventional Pain Management.


This 28th Annual Meeting will take place Thursday, March 19 through Saturday, March 21, 2026, at the Hilton New Orleans Riverside in New Orleans, Louisiana.


The 2026 Annual Meeting will provide the tools, knowledge, and connections you need to thrive in the evolving field of interventional pain management.

JOIN or RENEW your ASIPP Membership for the best registration rates.

Experts Pan Call to Break Up the Measles, Mumps, and Rubella Vaccine

"I cannot think of a single reason to implement such a concept"



The temporary CDC head's call to split apart the measles, mumps, and rubella (MMR) vaccine into three separate shots drew swift rebukes from pediatric and infectious disease experts.


"I call on vaccine manufacturers to develop safe monovalent vaccines to replace the combined MMR," Acting CDC Director Jim O'Neill said Monday on X. His statement affirmed an all-caps social media post last month by President Donald Trump to "break up the MMR shot into three totally separate shots (not mixed!)." O'Neill offered no details on why or how such an approach should be implemented.


The FDA approved the first combined MMR vaccine in 1971, and approved a second vaccine in 2022, both for use in patients ages 12 months and older.


Click here to read the full article.

Our Sponsor

Our Sponsor



Tuscany Pilot Offers Diagnostics in GP Offices — Will It Work?




Even in regions with strong healthcare systems, long waiting lists remain a challenge. Some local authorities are exploring ways to use the autonomy granted to them by the Constitution in healthcare to develop alternative solutions. In Tuscany, Italy, a pilot initiative is being launched to shift some of the simpler diagnostic procedures into general practitioners’ (GPs') offices. The dual aim is to reduce waiting lists and improve access for patients, particularly older adults and those living far from city centers.


Under this initiative, patients cared for by one of the 269 participating GPs will be able to undergo spirometry; arterial blood gas analysis; ECGs; Holter monitoring; thoracic and abdominal ultrasounds; carotid Doppler imaging; and lab tests, including creatinine and glycated hemoglobin, directly in their GP’s office.


The program defines two levels of patient management, depending on the complexity of the test and the GP’s individual expertise. Some participating GPs will also perform injections as part of pain management.


Click here to read the full article.


Only three test dates left this year - Apply today!



October 25, November 15,

& December 13



  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam

Exam Dates




How Luxury Medicine Redefines Value and Patient Trust




Physicians who treat high-income patients often adopt a differentiated model of care that extends beyond clinical procedures and encompasses the patient’s experience. 


Courses and mentorships in luxury healthcare marketing are most popular among dermatologists and plastic surgeons, although they also attract ophthalmologists, reproductive medicine specialists, vascular surgeons, and pediatricians.


According to Amanda Ferraz, from the luxury services segment of the healthcare market, Escola Superior de Propaganda e Marketing, as well as a professor at the Universidade de São Paulo, strategies to attract an exclusive audience can be adapted for any medical specialty with the right focus, and physicians outside this segment can apply key lessons to be perceived as high-value professionals in any setting.


Click here to read the full article.

 

We're excited to let you know that the new ASIPP Community, hosted by DocMatter, is now live!


The ASIPP Community on DocMatter will serve as a place for members to collaborate around clinical and research topics to advance the care of their interventional pain patients.


Click here to be a part of the conversation!

RFK Jr. 'Endangering the Health of the Nation,' Former Surgeons General Say

They criticize his actions harshly but do not explicitly call for his resignation


The actions of HHS Secretary Robert F. Kennedy Jr. "are endangering the health of the nation," six former surgeons general said Tuesday in a Washington Post opinion piece.


"Never before have we issued a joint public warning like this," wrote Jerome Adams, MD, MPH; Richard Carmona, MD, MPH; Joycelyn Elders, MD, MS; Vivek Murthy, MD, MBA; Antonia Novello, MD, MPH; and David Satcher, MD, PhD. "But the profound, immediate and unprecedented threat that Kennedy's policies and positions pose to the nation's health cannot be ignored."


"Over recent months, we have watched with increasing alarm as the foundations of our nation's public health system have been undermined," they continued. "Science and expertise have taken a back seat to ideology and misinformation. Morale has plummeted in our health agencies, and talent is fleeing at a time when we face rising threats -- from resurgent infectious diseases to worsening chronic illnesses."


Click here to read the full article.

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Spinal Epidural Abscess After Radiofrequency Denervation of the Lumbar Facets: Case Report


Emma Fu, MD, and Yian Chen, MD

 

RETROSPECTIVE STUDY

Buccal Buprenorphine for Postoperative Analgesia After Thoracic Surgery: Results of a Retrospective Cohort


Ryan Hopkins, MD, Krishna Theja Kudaravalli, MD, Brian Pittman, MS, Gavitt A. Woodard, MD, Andrew Dhanasopon, MD, Albert C. Perrino, Jr, MD, and Thomas R. Hickey, MD

 

NEW ISSUE NOW AVAILABLE

 

SYSTEMATIC REVIEW

Effectiveness of Peripheral Nerve Stimulation in Managing Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials


Laxmaiah Manchikanti, MD, Massab Bashir Khaira, MS, Amol Soin, MD, Alan D. Kaye, MD, PhD, Nebojsa Nick Knezevic, MD, PhD, Alaa Abd-Elsayed, MD, Mahendra Sanapati, MD, Vivekanand A. Manocha, MD, and Joshua A. Hirsch, MD

 

LITERATURE REVIEW

Optimizing Pain Relief in Refractory Thoracic Outlet Syndrome: The Role of Ultrasound-Guided Injections


Helen Gharaei, MD, and Negin Gholampoor, MBChB

 

RANDOMIZED CONTROLLED TRIAL

A Prospective, Randomized, Controlled Clinical Trial of High-Frequency Electromagnetic Coupling Powered Permanent Peripheral Nerve Stimulator for the Treatment of Chronic Craniofacial Pain


Salim M. Hayek, MD, PhD, Nameer Haider, MD, Ashwin Viswanathan, MD, Mehul Desai, MD, Jeffrey Rosenberg, MD, and Niek E. Vanquathem, BS




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!